Similar articles

• [Secondary debulking operation in ovarian cancer].

  Jänicke F, Schattenmann G, Kuhn W, Graeff H, Siewert JR. Jänicke F, et al. Chirurg. 1994 Jan;65(1):10-7. Chirurg. 1994. PMID: 8149793 Review. German. No abstract available.
• [Is there a standard therapy in advanced ovarian carcinoma?].

  Köchli OR. Köchli OR. Praxis (Bern 1994). 1999 Jan 21;88(4):123-5. Praxis (Bern 1994). 1999. PMID: 10067114 Review. German. No abstract available.
• Current aspects of adjuvant therapy of early stage ovarian cancer.

  McGuire WP. McGuire WP. Zentralbl Gynakol. 1998;120(3):93-7. Zentralbl Gynakol. 1998. PMID: 9556898 Review.
• Does secondary surgical cytoreduction improve survival in women with advanced ovarian cancer?

  Munkarah A. Munkarah A. Nat Clin Pract Oncol. 2005 Apr;2(4):188-9. doi: 10.1038/ncponc0131. Nat Clin Pract Oncol. 2005. PMID: 16264930 No abstract available.
• [Recurrent and 2nd line therapy in ovarian carcinoma: an overview of conventional systemic therapy modalities].

  du Bois A, Lück HJ, Meerpohl HG. du Bois A, et al. Zentralbl Gynakol. 1997;119(7):299-323. Zentralbl Gynakol. 1997. PMID: 9340970 Review. German.